Company intelligence / Profile preview

Qardio

Covina, California, United Statesqardio.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Qardio’s devices are clinically validated and FDA-approved where applicable. The company has demonstrated real-world impact in remote patient monitoring programs—such as a reported average reduction of systolic blood pressure by ~7.8 points in hypertension patients using its system in partnership with Side Health. Its products are widely used by consumers and healthcare providers globally for chronic disease management, cardiac rehab, telehealth integration, and proactive health tracking.

Therapeutic areas: EndocrinologyOtherCardiovascularNephrologyInfectious Diseases
Modalities: Device (Blood pressure monitor)Device (ECG monitor)Device (Smart scale)Device (Pulse oximeter)Device (Thermometer)Non-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Side Health (virtual specialty care provider)Integration partners via APIs/B2B collaborations

Beyond the preview

Go deeper on Qardio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qardio.

Explore the full profile